Log in to your Inderes Free account to see all free content on this page.
Acarix
0.545 SEK -0.91%1 investor is following this company
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACARIX
Daily low / high price
0.525 / 0.557
SEK
Market cap
563.08M SEK
Turnover
1.79M SEK
Volume
3.3M
Financial calendar
Interim report
22.08.2024
Interim report
07.11.2024
Annual report
13.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Försäkringsaktiebolaget, Avanza Pension | 6.3 % | 6.3 % |
Mikael Thorén | 3.9 % | 3.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Acarix Receives Sizeable Patch Reorder from Louisiana Primary Care Clinic
Acarix receives additional multi unit order from In-Home Concierge Practice
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio